Conclusion
The results suggest that isradipine might be a suitable drug for antihypertensive treatment in pregnancy. Intravenous bolus injections had no adverse effects on fetal circulation and, in contrast to other calcium antagonists of a similar type, had little effect on uterine activity. Doses of isradipine 0.3mg promptly normalised blood pressure in hypertensive pregnant women.
References
Ducsay CA, Thompson JS, Novy MJ. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. American Journal of Obstetrics and Gynecology 157: 1482–1486, 1987
Harake B, Gilbert RD, Ashwal S, Power GG. Nifedipine: effects of fetal and maternal hemodynamics in pregnant sheep. American Journal of Obstetrics and Gynecology 157: 1003–1008, 1987
Ingemarsson I, Arulkumaran S, Wide-Swensson D, Forman A, Andersson K-E. Effects of isradipine, a new calcium antagonist, on uterine activity postpartum. Acta Obstetricia et Gynecologica 68: 725–730, 1989
Wide-Swensson D, Ingemarsson I, Arulkumaran S, Andersson K-E. Effects of isradipine, a new calcium antagonist, on maternal cardiovascular system and uterine activity in labour. British Journal of Obstetrics and Gynaecology, in press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ingemarsson, I., Wide-Swensson, D., Andersson, K.E. et al. Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women. Drugs 40 (Suppl 2), 58–59 (1990). https://doi.org/10.2165/00003495-199000402-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199000402-00014